Recent regulatory developments have improved the landscape of the cannabis industry in the U.S. Canopy Growth and Aurora Cannabis are leaders in the Canadian market that could shift focus here. Despite progress, neither stock currently boasts attractive prospects. President Trump signed an executive order rescheduling cannabis from Schedule 1 to Schedule 3, a significant regulatory milestone. However, cannabis remains illegal federally, impacting operations. Aurora Cannabis’ financial results have been subpar, and Canopy Growth faces stiff competition. Investors should temper expectations as the recent win for the cannabis industry may not significantly boost these stocks’ prospects.

Read more at Nasdaq: Do These 2 Cannabis Stocks Have a Future?